Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa
NCT02465190 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2015-06-08
Summary
This is a case-control study embedded in a surveillance system to determine the effectiveness of antenatal maternal influenza vaccination against laboratory-confirmed influenza-associated hospitalised illness in infants \<6 months of age.
Conditions
- Influenza Viral Infections
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Bill and Melinda Gates Foundation
collaborator OTHER -
National Institute for Communicable Diseases, South Africa
lead OTHER
Principal Investigators
-
Shabir Madhi, PhD · National Institute for Communicable Diseases
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-09-30
- Completion
- 2017-12-31
Countries
- South Africa
Study Locations
More Related Trials
-
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
NCT01985620 ·Status: UNKNOWN ·Phase: NA
-
Safety of H1N1 Influenza Vaccination in Pregnant Women
NCT01842997 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women
NCT01024400 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Influenza Vaccine in Pregnancy Part 2
NCT00593970 ·Status: COMPLETED
-
Influenza Vaccine in Pregnant Women
NCT00905125 ·Status: COMPLETED ·Phase: PHASE2
-
Brief Influenza Vaccine Education to Pregnant Women
NCT01772901 ·Status: COMPLETED ·Phase: NA
-
Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants
NCT05436184 ·Status: ACTIVE_NOT_RECRUITING
-
Field Trial of Maternal Influenza Immunization in Asia
NCT01034254 ·Status: COMPLETED ·Phase: PHASE3
-
Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy
NCT04579822 ·Status: UNKNOWN
-
Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
NCT00328107 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009
NCT00735410 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
NCT01494740 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women
NCT05457894 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
NCT00511914 ·Status: COMPLETED ·Phase: PHASE3
-
H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women
NCT01012557 ·Status: COMPLETED ·Phase: NA
-
An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh
NCT04998344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
NCT02313740 ·Status: COMPLETED
-
Novartis H1N1 Vaccine in Pregnant Women
NCT00992719 ·Status: COMPLETED ·Phase: PHASE2
-
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine in Premature Infants
NCT00455169 ·Status: COMPLETED
-
Response to Influenza Vaccine During Pregnancy
NCT03888989 ·Status: TERMINATED ·Phase: PHASE1
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)
NCT01551823 ·Status: COMPLETED ·Phase: PHASE3